SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-20-007529
Filing Date
2020-05-01
Accepted
2020-05-01 17:10:18
Documents
11

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 649005
2 ex1-2.htm EX-1.2 277689
3 ex4-3.htm EX-4.3 486179
4 ex4-5.htm EX-4.5 168892
5 ex4-6.htm EX-4.6 170676
6 ex4-7.htm EX-4.7 140743
7 ex5-1.htm EX-5.1 45003
8 ex23-1.htm EX-23.1 3581
9 forms-3_001.jpg GRAPHIC 8970
10 forms-3_002.jpg GRAPHIC 6076
11 ex5-1_001.jpg GRAPHIC 2558
  Complete submission text file 0001493152-20-007529.txt   1967470
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237975 | Film No.: 20841771
SIC: 2836 Biological Products, (No Diagnostic Substances)